In vitro and in vivo approaches demonstrating the antiproliferative activity of pomegranate seed proteins and peptides on breast cancer
PLOS One · 2025
DOI: 10.1371/journal.pone.0330895 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Miriam Guzmán-Lorite und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Alcalá, Departamento de Química Analítica, Química Física e Ingeniería Química, Ctra. Madrid-Barcelona Km. 33.600, 28871 Alcalá de Hen…. Hauptthemen laut MEDLINE: Pomegranate, Breast Neoplasms, Seeds, Plant Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comunidad de Madrid, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Pomegranate seed proteins and peptides exhibit high antioxidant capacity according to previous work carried out by our group. The present work aims to evaluate the antitumoral potential of pomegranate seed protein isolates (PIs), obtained using two different procedures, pressurized liquids (PLE) and high-intensity focused ultrasounds (HIFU), and their hydrolysates on breast cancer cells (HCC1806) and immunodeficient mice (Hsd:Athymic Nude- Foxn1 nu ). The treatment of HCC1806 cells with increasing concentrations of pomegranate seed PIs and the hydrolysates significantly reduced cell viability. At a concentration of 4 mg/mL (PLE PI), 2 mg/mL (HIFU PI), and 2.4 mg/mL (hydrolysates), all treatments significantly reduced breast cancer cell migration and metalloproteinase 9 (MMP-9) activity (active and pro form), and enhanced cell adhesion. Additionally, a reduction in the proliferation capacity of HCC1806 cells was observed, most likely due to cell cycle arrest and the apoptotic effect of PLE PI and its hydrolysate. In vivo experiments with pomegranate seed hydrolysates confirmed their antitumoral capacity, observing significant reductions in the tumor volume and weight after treating with pomegranate proteins and peptides, as well as in metalloproteinase (MMP) activity and vascular endothelial growth factor (VEGF) expression. In addition to proteins and peptides, the anticancer potential may also be related to the presence of phenolic compounds, especially abundant in the PLE extracts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Universidad de Alcalá, Departamento de Química Analítica, Química Física e Ingeniería Química, Ctra. Madrid-Barcelona Km. 33.600, 28871 Alcalá de Henares, Madrid, Spain.
- Universidad de Alcalá, Departamento de Biología de Sistemas, Ctra. Madrid-Barcelona Km. 33.600, 28871 Alcalá de Henares, Madrid, Spain.
- Universidad de Alcalá, Instituto de Investigación Química "Andrés M. del Río", Ctra. Madrid-Barcelona Km. 33.600, 28871 Alcalá de Henares, Madrid, Spain.
ORCID-Profile: Miriam Guzmán-Lorite
Förderung
- Comunidad de Madrid
- Ministerio de Ciencia e Innovación
Zitieren
APA
Guzmán-Lorite, M., Muñoz-Moreno, L., Marina, M. L., Carmena, M. J., & García, M. C. (2025). In vitro and in vivo approaches demonstrating the antiproliferative activity of pomegranate seed proteins and peptides on breast cancer. PLOS One. https://doi.org/10.1371/journal.pone.0330895
Vancouver
Guzmán-Lorite M, Muñoz-Moreno L, Marina ML, Carmena MJ, García MC. In vitro and in vivo approaches demonstrating the antiproliferative activity of pomegranate seed proteins and peptides on breast cancer. PLOS One. 2025. doi:10.1371/journal.pone.0330895
BibTeX
@article{GuzmnLorite2025,
author = {Guzmán-Lorite, Miriam and Muñoz-Moreno, Laura and Marina, María Luisa and Carmena, María José and García, María Concepción},
title = {In vitro and in vivo approaches demonstrating the antiproliferative activity of pomegranate seed proteins and peptides on breast cancer},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0330895}
}
EUVIMED